Osman N. Özeş - Concepedia

Author

Osman N. Özeş

Indiana University School of Medicine ORCID

Also Known As

O N Özeş, O OZES, O Ozes, O. N. Ozes, OSMAN N. OZES, OSMAN NIDAI OZES, OSMAN NİDAİ ÖZEŞ, Osman N Ozes, Osman N. Ozes, Osman N. Özeş

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Indiana University School of Medicine Akdeniz University Indiana University – Purdue University Indianapolis Indiana University Bloomington University of California, San Francisco

About

Osman N. Özeş is an author at Indiana University School of Medicine specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	822
2	Cell Biology	8	8	672
3	Immunology	5	5	473
4	Pathology	5	5	336
5	Cellular Physiology	2	2	150

Osman N. Özeş

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
NF-κB-HOTAIR axis links DNA damage response, chemoresistance and cellular senescence in ovarian cancer Ali Özeş, Dave Miller, Osman N. Özeş, Oncogene MedicineCancer Cell BiologyCellular SenescenceCell BiologyCancer Biology	2016	262
Cell Type-specific Expression of the IκB Kinases Determines the Significance of Phosphatidylinositol 3-Kinase/Akt Signaling to NF-κB Activation Jason A. Gustin, Osman N. Özeş, Hakan Akça, Journal of Biological Chemistry	2004	198
Tumor Necrosis Factor Employs a Protein-tyrosine Phosphatase to Inhibit Activation of KDR and Vascular Endothelial Cell Growth Factor-induced Endothelial Cell Proliferation Li‐Wha Wu, James D. Dunbar, Osman N. Özeş, Journal of Biological Chemistry ImmunologyPathologyOxidative StressInflammationTumor Necrosis Factor	2000	127
VRAP Is an Adaptor Protein That Binds KDR, a Receptor for Vascular Endothelial Cell Growth Factor Li‐Wha Wu, Lindsey D. Mayo, James D. Dunbar, Journal of Biological Chemistry ImmunologyCell DeathPredominant Vrap MrnaCellular PhysiologyAngiogenesis	2000	123
A Comparison of Interferon-Con1 with Natural Recombinant Interferons-α: Antiviral, Antiproliferative, and Natural Killer-Inducing Activities Osman N. Özeş, Zvi Reiter, Susan Blakeley Klein, Journal of Interferon Research ImmunodeficienciesDaudi CellsImmunologyPathologyImmunotherapeutics	1992	116
Stat4 Regulates Multiple Components of IFN-γ-Inducing Signaling Pathways Victoria A. Lawless, Shangming Zhang, Osman N. Özeş, The Journal of Immunology	2000	115
Type 1 TNF Receptor Forms a Complex with and Uses Jak2 and c-Src to Selectively Engage Signaling Pathways That Regulate Transcription Factor Activity Roxana Pincheira, Ariel F. Castro, Osman N. Özeş, The Journal of Immunology	2008	81
Tumor necrosis factor activates CRE-binding protein through a p38 MAPK/MSK1 signaling pathway in endothelial cells Jason A. Gustin, Roxana Pincheira, Lindsey D. Mayo, American Journal of Physiology-Cell Physiology Endothelial CellsApoptosisImmunologyP38 Mapk/msk1Pathology	2004	73
Protein kinase A-mediated phosphorylation regulates STAT3 activation and oncogenic EZH2 activity Ali Özeş, Nick Pulliam, Mustafa Gökhan Ertosun, Oncogene Systems BiologySignal TransductionSignaling PathwayCell RegulationReceptor Tyrosine Kinase	2018	40
A dual anti-tumor effect of a combination of interferon-α or interleukin-2 and 5-fluorouracil on natural killer (NK) cell-mediated cytotoxicity Zvi Reiter, Osman N. Özeş, Lawrence M. Blatt, Clinical Immunology and Immunopathology Cancer ImmunosurveillanceMedicineImmunologyTumor ImmunityCell Death	1992	34

Page 1